[Immunopathological bases of the treatment of glomerulonephritis].
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D005921:Glomerulonephritis / Q000188:drug therapy* / Q000276:immunology; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007105:Immune Complex Diseases / Q000188:drug therapy*; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007213:Indomethacin / Q000627:therapeutic use; D007678:Kidney Glomerulus / Q000276:immunology; D008407:Mast Cells / Q000276:immunology
D000893:Anti-Inflammatory Agents; D007166:Immunosuppressive Agents; D006493:Heparin; D007213:Indomethacin
Le basi immunopatologiche della terapia delle glomerulonefriti.